Focus Stocks
Trading Idea - Is Google close to Resistance?
Published on Thursday, 09 February 2012 07:48 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of Google Inc. (NASDAQ:GOOG) are trading very close to calculated resistance at $610.83 with the current price action closing at just $609.85 placing the stock near levels that make it difficult to buy.
Google Inc. (NASDAQ:GOOG) is a global technology company that provides a web based search engine through its website. Its automated search technology helps users to obtain instant access to relevant information from its online index. The company provides targeted advertising and Internet search solutions, including web, image, groups, directory, and news searches.
Google's current stock range is defined by current calculated support defined at $564.55 and by the resistance level at $610.83, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Google, as the stock is well above support, however, as the stock pulls back towards $564.55 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $610.83 then traders will get an opportunity to enter Google stock by establishing a position as the stock moves to a higher range.
Related Articles
- Stocks End Flat on Greek Woes
- Google to Provide CornellNYC Tech with Free Office Space for More Than 5 Years: Commitment to Training and Developing Engineering Talent in New York Cited as Key Reasons by CEO Larry Page
- Facebook IPO A Dud On Day One
- Close to the 50 Day Moving Average: Google
- Best ETFs For Facebook Exposure
- Google Is Near Resistance
- Stocks Fall for Fourth Day on European woes
- NASDAQ 100 Mid-day Update: Lower Top Performers: MU, GOOG, EXPE
- Google Is Between the 50 and 200 Day Moving Averages
- Google Upside Looming?
Related Partner Headlines
- Google Inc. (GOOG): Today's Featured Internet Loser - TheStreet.com
- Social Media ETF Index Weights Facebook at 8.8% - Benzinga
- The Digital Skeptic: DuckDuckGo Cooks Google's Goose - TheStreet.com
- Mark Cuban Bought Nearly $5 Million in Facebook Stock! - Benzinga
- Earnings Preview: Will NetApp End its Share Price Decline? - Benzinga
- 10 Overused Startup Buzzwords - Benzinga
- Google Announces Closing of Acquisition of Motorola Mobility - Benzinga
- Benzinga's M&A Chatter for Monday May 21, 2012 - Benzinga
- Google Chrome Is The New Worldwide Champ - TheStreet.com
- Happy Birthday YouTube - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









